Search PubMed⌕ Search

Biomedical subjects

H J Lisch

Publications and source records attributed to H J Lisch.

At least 37 records · Page 2Linked to original sources
PubMed1983

[Diagnosis of diabetes in pregnancy. Accuracy and prognostic value].

Pregnancy can impair glucose tolerance severely enough to increase the perinatal mortality rate. In the presence of easily recognizable signs pointing to diabetes mellitus we have performed an oral glucose tolerance test. Among 634 patients who were investigated, 151 or 23.8% had impaired glucose tolerance. As there were 11,017 pregnancies in the observation period from January 1976 to May 1981, the detection rate of impaired glucose tolerance was 1.37%. The patients were treated by diet or by diet plus insulin (105 patients). The observed favourable fetal outcome justifies and promotes the proposed diagnostic procedures.

Adult↗
PubMed1982

Effect of treatment of the concentration of lipoproteins and the postheparin-lipolytic activity in the plasma of noninsulin-dependent diabetics.

To study the effect of treatment on plasma lipid and lipoprotein concentration and on postheparin-lipolytic activity (PHLA) in plasma, 26 noninsulin-dependent diabetics were investigated who were treated with maximally effective doses of glibenclamide. The patients were randomly divided into two groups: In group I, glibenclamide was replaced by a long-acting insulin preparation given once daily at variable doses until satisfactory metabolic control was achieved. In group II, glibenclamide was replaced by placebo. At weeks 0, 1, 3, 7, and 12 after change of treatment, the following parameters were determined: Blood glucose, plasma concentrations of cholesterol, triglycerides, phospholipids, HDL cholesterol, very-low-density lipoproteins, intermediate-density lipoproteins, low density lipoproteins, high-density lipoproteins2 (HDL2), HDL3 and PHLA. At week 0, no statistically significant differences existed between group I and group II with respect to all parameters mentioned above. The replacement of glibenclamide by insulin resulted in a continuous decrease of blood glucose (p less than 0.01) with a concomitant increase in HDL2 (p less than 0.01) and in PHLA (p less than 0.01) during the period of investigation. In contrast, replacement of glibenclamide by placebo exerted no significant influence on all determined parameters during 12 weeks. These data suggest that in noninsulin-dependent diabetics, who are inadequately controlled by sulfonylureas, an adequate insulin substitution is necessary to correct, apart from glucose metabolism, the impaired lipoprotein metabolism of diabetes mellitus. Sulfonylureas per se seem not to decrease the HDL2 fraction nor the PHLA.

Aged↗
PubMed1982

[Concentrations of the main lipoprotein density classes in disturbances of thyroid function in man (author's transl)].

The concentrations of the main lipoprotein density classes and the postheparin lipolytic activity (PHLA) were determined in the plasma of 12 hyperthyroid and eight hypothroid patients in comparison with 12 euthyroid, metabolically healthy individuals. Low-density lipoproteins (LDL) and high-density lipoproteins2 (HDL2) were decreased in hyperthyreosis (p less than 0.01) and increased in hypothyreosis (p less than 0.01). No significant differences could be detected with respect to the concentrations of very low-density lipoproteins (VLDL) as well as for HDL3, whereas intermediate-density lipoproteins (IDL) were higher in hypothyreotics than in controls (p less than 0.05). PHLA was increased in hyperthyreosis (p less than 0.01) and decreased in hypothyreosis (p less than 0.01). The chemical composition of LDL and HDL2 as well as the apolipoprotein composition of the protein moiety of HDL2 in hyperthyreosis and in hypothyreosis did not significantly differ from those in the control group. When data from all individuals studied were analyzed, no significant relationship could be detected between the concentrations of VLDL and HDL2, whereas HDL2 and PHLA correlated in a negative manner (p less than 0.05). It is suggested that HDL2, in addition to LDL, acts as carrier protein for the cholesterol increasingly yielded in hypothyreosis.

Adult↗
PubMed1981

Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics.

In order to study the lipoprotein pattern in diabetes mellitus, plasma lipoproteins were isolated by rate zonal centrifugation in 12 control subjects (median fasting blood glucose level: 80 mg/dl (range: 74-86)), 14 diabetic patients treated by diet alone 104 mg/dl (76-153), 27 patients treated by diet plus insulin (180 mg/dl (106-404)), and 32 patients treated by diet plus sulphonylurea [178 mg/dl (103-361)]. No significant differences of median relative body weight existed between the four groups. Neither the diabetic group on diet alone nor the insulin-treated group differed significantly from control subjects with respect to lipid and lipoprotein concentrations. Diabetics treated with diet plus sulphonylurea, however, differed significantly from the control group with regard to the following parameters (median and range); plasma triglycerides (210 [75-620) mg/dl; p less than 0.01)] and intermediate density lipoproteins (65 (10-338) mg/dl; p less than 0.05)) were higher; low density lipoproteins (236 (82-418) mg/dl; p less than 0.05)) and high density lipoproteins2 (HDL2) [51 (12-121) mg/dl; p less than 0.01)] concentrations were lower. When data from all 85 studied individuals were analysed together, significant positive correlations were observed between fasting blood glucose and plasma triglyceride concentration (r = 0.28, p less than 0.01), and between fasting blood glucose and plasma very low density lipoproteins (VLDL) (r = 0.23, p less than 0.05). A negative correlation was found between blood glucose and plasma HDL2 (r = -0.29, p less than 0.01). In addition, VLDL correlated negatively with HDL2 (r = -0.89, p less than 0.001) but not with plasma HDL3 concentration. It is concluded that the deranged lipoprotein metabolism in diabetes mellitus may be better controlled by insulin than by sulphonylureas.

Adult↗
PubMed1981

[Glucosuria of pregnancy: frequency of diabetes mellitus and renal glucosuria (author's transl)].

From 1974 to 1979 352 pregnant women were referred to our diabetic outpatient clinic because of glycosuria during pregnancy. In 118 women (34%) oral glucose tolerance tests revealed a pathologic glucose tolerance. In 234 pregnant women (66%) a "renal glycosuria of pregnancy" was found to be the cause for the observed glycosuria. A pathologic glucose tolerance was relatively more frequent in the 3rd trimenon, whereas renal glycosuria was observed to be more frequent in the second trimenon.

Blood Glucose↗
PubMed1980

[The effect of biguanides on insulin sensitivity of maturity onset diabetics (author's transl)].

The effect of short-term treatment with biguanides on the insulin sensitivity (KITT) of maturity onset diabetics was tested by means of an insulin tolerance test. On the basis of their long-term blood glucose response to biguanide therapy, the patients were classified retrospectively as biguanide-responsive subjects (n = 10) and as biguanide-non-responsive subjects (n = 10). Both group showed the typical marked reduction in insulin sensitivity of maturity onset diabetics. After three days of biguanide treatment, a highly significant (p less than 0.001) increase in insulin sensitivity was noted in the group of biguanide responders, which was significantly (p less than 0.02) correlated with their previous blood glucose response to long-term biguanide therapy. In the biguanide non responders, insulin sensitivity was not significantly altered by biguanides. It is suggested that the blood glucose lowering action of biguanides is due, at least in a definite group of patients with maturity onset diabetes, to a reduction of insulin resistance.

Aged↗
PubMed1980

Guanfacine and glucose metabolism.

1. The effect of a single dose of guanfacine 1.0 mg intravenously on glucose metabolism was compared with placebo. Six men participated in the cross-over study. 2. An oral glucose tolerance test was performed 90 min after the administration of the medicaments. Guanfacine had no effect on blood glucose, insulin or the 'Insulinogenic index'.

Antihypertensive Agents↗
PubMed1978

Activation of adipose tissue lipoprotein lipase by lipoprotein fractions from normals and patients with type v hyperlipoproteinemia.

The effects of the main lipoprotein density classes on the human adipose tissue lipoprotein lipase activity were studied. A dose-dependent stimulation of lipoprotein lipase activity was obtained for HDL and, to a lesser extent, for VLDL on a constant weight basis. LDL exerted virtually no effect. At higher concentrations, HDL as well as VLDL inhibited the stimulated lipolytic activity. In type V hyperlipoproteinemia, the stimulating effect of VLDL and of HDL was significantly lower, whereas the inhibiting action of HDL was markedly increased.

Adipose Tissue↗
PubMed1978

[Relationship between the plasma concentration of the high density lipoproteins (HDL) and the intravenous fat tolerance in normo-and hypertriglyceridaemics].

The relationship between the plasma concentration of high-density-lipoprotein(HDL)-cholesterol, very-low-density-lipoprotein(VLDL)-triglycerides, and low-density-lipoprotein(LDL)-cholesterol and the fractional removal rate (K2) of an intravenously administered fat emulsion (Intralipid) was investigated in 13 normo- and 34 hypertriglyceridaemics. A highly significant correlation (p less than 0,001) between the plasma concentration of HDL-cholesterol and the fractional removal rate of exogenous triglycerides was found for both groups. No significant relationship existed between the concentration of VLDL-triglycerides and of LDL-cholesterol and the removal rate of exogenous triglycerides. These observations suggest a major role of HDL in the removal of plasma triglycerides.

Adolescent↗
PubMed1978

Initial cholesterol esterification rate in hyperlipoproteinaemia: effects of triglyceride-rich lipoproteins.

The initial cholesterol esterification rate (LCAT activity) was determined in ninety-four hyperlipidaemic subjects. LCAT activity was elevated in hypertriglyceridaemia, whereas patients with hypercholesterolaemia had normal activities. In hypertriglyceridaemic subjects LCAT activity correlated with the concentrations of d less than 1.006 lipoproteins, plasma triglycerides, cholesterol and cholesterol esters and phospholipid levels. Addition of d less than 1.006 lipoprotein to normal plasma resulted in a dose dependent stimulation of enzyme activity with a sigmoidal response curve. When the d less than 1.006 lipoproteins were removed from hypertriglyceridaemic plasma by ultracentrifugation, the enzyme activity in the residual d greater than 1.006 fraction dropped, but still was higher than in normal plasma and correlated with the amount of d less than 1.006 lipoproteins originally present. Thus, high LCAT activity in hypertriglyceridaemia cannot be explained solely by the presence of an increased d less than 1.006 lipoprotein concentration. An increase of enzyme concentration or changes in concentration or composition of other lipoproteins (high density lipoproteins) may contribute to the high LCAT activity in hypertriglyceridaemia.

Adult↗
PubMed1977

Assay and characterization of serum-stimulated lipolytic activity in homogenates of human adipose tissue.

An assay of lipolytic activity in human adipose tissue is described, in which native homogenates of the adipose tissue yield the enzyme, as well as the triglyceride substrate, and the emulsifying phospholipids. The lipolytic activity in the presence of serum is characterized mainly as lipoprotein lipase activity by a pH-optimum of 8.0, by the fact that serum is necessary for full activity, and that it is inhibited by 1 M NaCl and by protamine. At serum concentrations of higher than 50% a marked inhibition of the lipolysis is observed. Noradrenaline, insulin, and heparin have no effect on the serum-stimulated lipolytic activity.

Adipose Tissue↗
PubMed1977

[Myocardial performance during therapeutic starvation in obese subjects].

The effect was studied of therapeutic total starvation of two weeks' duration on myocardial performance in 12 obeses patients. Half of these subjects were trained for 10 minutes daily on a bicycle ergometer, whilst the other half had no training. After two weeks of total fasting no significant changes were observed either inter- or intracollectively with regard to systolic time intervals, ejection fraction and the index of myocardial contractility, nor in respect to serum electrolytes. Physical training had no influence on the systolic time intervals and the other noninvasive parameters of left ventricular performance. The inclusion of previous data obtained in a similar investigation enabled the establishment of a correlation between the serum potassium level and the ejection franction.

Adult↗
PubMed1977

[Pathophysiology of lipolysis in human adipose tissue (author's transl)].

Lipolysis in human adipose tissue was measured as glycerol release in isolated fat cells and in adipose tissue homogenates. In isolated fat cells lipolysis proceeded optimally at pH 7.4, was stimulated 3.5 fold by noradrenaline and was not influenced by serum or protamine. In adipose tissue homogenates lipolysis was stimulated 4 fold by serum. Serum-stimulated lipolytic activity was optimal at pH 8.0, was inhibited by 1 M sodium chloride and protamine and was not influenced by noradrenaline. Lipolytic activity in isolated fat cells is ascribed on the basis of these observations mainly to the action of hormone-sensitive lipase. whereas lipolysis in adipose tissue homogenates in the presence of serum seems to be regulated by lipoprotein lipase. Thus, the lipolytic processes involved in the mobilization of triglycerides from adipose tissue and in the uptake or triglycerides into adipose tissue can be assessed separately, using the two described methods. The re-esterification of FFA, the second pathway in the mobilization of triglycerides, has also been investigated.

Adipose Tissue↗
PubMed1977

[Effect of tibric acid (CP-18.254) on plasma lipids in patients with primary endogenous hyperlipoproteinemia].

Tibric acid [CP-18.524; 2-chloro-5-(3,5-dimethyl-piperidino-sulfonyl-benzoic acid], a new hypolipidemic drug was given to 20 patients with primary endogenous hyperlipoproteinemia of type II, III, IV and V Fredrickson in a daily dose of 1.5 g for 1 year. As compared to a 4-week placebo period, the treatment with tibric acid led to a significant decrease in plasma cholesterol in 6 type-II patients (p less than 0.02) and to a significant decrease in plasma cholesterol and triglycerides in 6 type-III patients (p less than 0.001 and p less than 0.001, resp.) and in 4 type-IV patients (p less than 0.001 and p less than 0.001, resp.). No significant effect of tibric acid on plasma lipids was noted in 4 type-V patients. Apart from a moderate nausea in two patients, no side effects occurred.

Adult↗